Title
Effect of Fibrin Sealant on Early Wound Healing
Evaluation of Early Wound Healing Following Use of Fibrin Sealant (FS) in Periodontal Surgery. A Controlled Randomized Clinical Trial.
Phase
Phase 4Lead Sponsor
Chhattisgarh Dental College and Research InstituteStudy Type
InterventionalStatus
Completed No Results PostedIndication/Condition
PeriodontitisIntervention/Treatment
human fibrin ...Study Participants
15The aim of this randomized controlled clinical trial is to compare wound healing after the use of fibrin sealant and sutures for gum surgeries. 15 patients requiring gum surgery for their periodontal (gum)problems are selected and invited. Two regions will be operated in a selected patient. One region will receive fibrin sealant (test site) and the other region will get sutures (control site). Wound healing will be assessed by evaluating inflammatory markers, Interleukin 1beta and interleukin 8, from a non invasively collected gum fluid.
Hypothesis. Fibrin sealant use will result in less inflammation seen through reduced levels of interleukin (1beta and 8) compared to use of sutures.
Fibrin Sealant 4ml (Baxter Tisseel)
Black silk 000
One quadrant surgically elevated will be closed with fibrin sealant
The surgically elevated flap is closed with non resorbable sutures.
Inclusion Criteria: A subject has to be between the ages of 18 and 60 years. Severe Periodontitis: Presence of a jaw with each quadrant having atleast 4 teeth with a probing depth of ≥ 6mm and is indicated for periodontal flap surgery. Compliance: Only patients with optimal compliance, as assessed during the cause-related phase of therapy, are selected. Good oral hygiene: Full-mouth plaque score (FMPS) < 25%. Low levels of residual infection: Full-mouth bleeding score (FMBS) < 25%. Endodontic status: Teeth had to be vital or properly treated with root canal therapy Exclusion Criteria: History of any systemic disease such as diabetes mellitus, osteoporosis, unstable or life-threatening conditions, bleeding disorder, undergoing antibiotic or other antimicrobial therapy. Current or former smokers. Had undergone periodontal therapy in the past 6 months, or exhibit poor plaque control after phase I therapy. Mobility of selected teeth. Pregnant or lactating women.